A study of shatpushpa arka in infantile colic at age of day 1 to 3 months
Phase 2
- Conditions
- Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Registration Number
- CTRI/2023/06/054335
- Lead Sponsor
- DR Shital Kakade
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Full term healthy neonates
Babies suffering from definitive symptoms of Infantile Colic
Babies whose parents are ready to participate in the clinical trial by giving informed written consent
Exclusion Criteria
Patients who require surgical management
Patients associated with symptoms like vomiting diarrhea fever or any other pathology
Patients with congenital anomalies
Patients with unstable vitals
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To Reduce The Episodes Of Infantile ColicTimepoint: Third Day And Fifth Day
- Secondary Outcome Measures
Name Time Method To Reduce The Irritability Due To Infantile ColicTimepoint: Shatpushpa Arka Will Be Given On 0th,5th And 7th Day <br/ ><br>Follow Ups Will Be On 5th And 7th Day <br/ ><br>Total Duration Of Study Will Be 5 Days